Skip to main content Accessibility help
×
Hostname: page-component-cb9f654ff-mnl9s Total loading time: 0 Render date: 2025-08-06T20:56:41.813Z Has data issue: false hasContentIssue false

69 - Haloperidol

Published online by Cambridge University Press:  06 October 2020

Stephen D. Silberstein
Affiliation:
Thomas Jefferson University, Philadelphia
Michael J. Marmura
Affiliation:
Thomas Jefferson University, Philadelphia
Hsiangkuo Yuan
Affiliation:
Thomas Jefferson University, Philadelphia
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

THERAPEUTICS

Brands

• Haldol, Haldol Decanoate, Dozic, Serenace

Generic?

• Yes

Class

• Antipsychotic

Commonly Prescribed for

(FDA approved in bold)

Tics in Gilles de la Tourette syndrome (GTS) in adults and children

Psychotic disorders

Refractory severe behavioral problems in children with combative explosive hyperexcitability (oral only)

Short-term treatment in children of excessive motor activity with conduct disorder (oral only)

Schizophrenia (Decanoate only)

• Acute mania

• Nausea and vomiting

• Acute migraine

• Hiccup

• Delirium

• Behavioral disturbances in dementia

• Augmentation for refractory obsessivecompulsive disorder

How the Drug Works

• It is a butyrophenone derivative that exerts its function at multiple levels of the CNS

• It is a D2-4 inverse agonist (for positive symptoms), 5-HT2A antagonist (for negative symptoms), and α1A antagonist

• Due to negligible affinity for H1 and M1 receptors, it has relatively lower risk for sedation, weight gain, and orthostatic hypotension but with more dyskinesia

• Antiemetic action is probably through blocking the dopamine receptors in the chemoreceptor trigger zone

How Long Until It Works

• Psychosis: usually within a week

• GTS: weeks to months

• Acute migraine: usually within hours

If It Works

• Use at lowest effective dose

• Monitor QTc interval

• Continue to assess effect of the medication and if it is still needed

If It Doesn't Work

• Psychosis: increase dose or change to another agent

• GTS: discontinue or change to another agent

Best Augmenting Combos for Partial Response or Treatment-Resistance

• Tics and GTS symptoms may change over time. Many patients improve with age. Behavioral and psychological therapies are useful. Education and reassurance are all that is needed in mild cases

• Indentify and treat comorbid conditions, such as ADHD or obsessive-compulsive disorder

• In GTS, α2 agonists such as clonidine, guanfacine, reserpine, and other neuroleptics are also useful

• For intractable migraine, often combined with NSAIDs or dihydroergotamine

Information

Type
Chapter
Information
Essential Neuropharmacology
The Prescriber's Guide
, pp. 254 - 257
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Haloperidol
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.070
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Haloperidol
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.070
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Haloperidol
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.070
Available formats
×